Method Development and Validation for Simultaneous Estimation of Dexlansoprazole and Meloxicam by Rp-Hplc

To develop a method for simultaneous estimation of Dexlansoprazole and Meloxicam by RP-HPLC and validate the developed method according to ICH guidelines. The column used for method development of Dexlansoprazole and Meloxicam was Hypersil-BDS, C18, 250*4.6 mm, 5μ. Methanol and Acetonitrile were used in the ration of 60:40 for the method development. The developed method was validated for various parameters such as specificity, linearity, range, accuracy, precision, system suitability, robustness, ruggedness etc. The method was developed and optimized method was chosen and validated and the results were tabulated according to ICH guidelines. The result obtained in this study demonstrated that the HPLC method described is specific, accurate, precise, linear, ruggedness, robustness and stability indicating for the simultaneous determination of Dexlansoprazole and Meloxicam.

[1]  B. Morelli.  Spectrophotometric assay for chloramphenicol and some derivatives in the pure form and in formulations. , 1987, Journal of pharmaceutical and biomedical analysis.

[2]  S. Ahuja.  Impurities evaluation of pharmaceuticals , 1998 .

[3]  J. Blanca,et al.  Determination of chloramphenicol residues in shrimps by liquid chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  N H Zawilla,et al.  Determination of meloxicam in bulk and pharmaceutical formulations. , 2003, Journal of pharmaceutical and biomedical analysis.

[5]  E. Nemutlu.  Validated Determination of Meloxicam in Tablets by Using UV Spectrophotometry , 2004 .

[6]  R. Bhardwaj,et al.  Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[7]  S. Kır,et al.  Method development and validation for the analysis of meloxicam in tablets by CZE. , 2003, Journal of Pharmaceutical and Biomedical Analysis.

[8]  Shivaprakash,et al.  LC determination and pharmacokinetics of meloxicam. , 2002, Journal of pharmaceutical and biomedical analysis.

[9]  D. Corbin,et al.  Determination of serum chloramphenicol utilizing gas--liquid chromatography and electron capture spectrometry. , 1966, Analytical chemistry.

[10]  D Lochmann,et al.  Tablet identification using near-infrared spectroscopy (NIRS) for pharmaceutical quality control. , 2008, Journal of pharmaceutical and biomedical analysis.

[11]  S. Kır,et al.  A Validated Hplc Method for the Determination of Meloxicam in Pharmaceutical Preparations , 2022 .

[12]  S. Eremin,et al.  Determination of chloramphenicol in milk by a fluorescence polarization immunoassay , 2010 .

[13]  S. Vignaduzzo,et al.  Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations. , 2008, Journal of pharmaceutical and biomedical analysis.

[14]  S. Meena,et al.  An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. , 2005, Journal of pharmaceutical and biomedical analysis.

[15]  E. Yilmaz,et al.  Development of an improved method for trace analysis of chloramphenicol using molecularly imprinted polymers. , 2007, Journal of chromatography. A.

[16]  C. Jang,et al.  Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.